secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0000950170-23-028007
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla stockholders elect three Class III directors at June 14, 2023 annual meeting
--------------------------------------------------------------------------------

- All three director nominees (Short, Smith, Williams) elected with ~79% votes for excluding broker non-votes.
- Ratification of Ernst & Young as auditor for FY2023 passed with over 36.5M votes for.
- Non-binding advisory vote on executive compensation approved with ~27.5M for, ~1.4M against.
- 78.31% of outstanding shares represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000095017023028007/0000950170-23-028007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000095017023028007/bcab-20230614.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-028007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer